Article
Hybrid nonribosomal peptide-polyketide interfaces in epothilone biosynthesis: minimal requirements at N and C termini of EpoB for elongation.
Chemistry & biology - 1 Nov 2004
Liu Fei, Garneau Sylvie, Walsh Christopher T
Abstract excerpt
Epothilone (Epo) D, an antitumor agent currently in clinical trials, is a hybrid natural product produced by the combined action of nonribosomal peptide synthetases (NRPS) and polyketide synthases (PKS). In the epothilone biosynthetic pathway, EpoB, a 165 kDa NRPS is inserted into an otherwise entirely PKS assembly line, forming two hybrid NRPS-PKS interfaces. In light of the terminal linker effect previously...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
